Corient Capital Partners’s Pfizer PFE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$6.08M	Hold	116,005	–	–	0.46%	50
2022 Q2	$6.08M	Buy	116,005 +15,715	+16%	+$824K	0.46%	52
2022 Q1	$5.19M	Buy	100,290 +8,928	+10%	+$462K	0.34%	67
2021 Q4	$5.4M	Buy	91,362 +4,281	+5%	+$253K	0.36%	64
2021 Q3	$3.75M	Buy	87,081 +4,434	+5%	+$191K	0.27%	85
2021 Q2	$3.24M	Buy	82,647 +6,482	+9%	+$254K	0.24%	93
2021 Q1	$2.76M	Sell	76,165 -8,146	-10%	-$295K	0.24%	87
2020 Q4	$3.1M	Sell	84,311 -4,051	-5%	-$149K	0.31%	79
2020 Q3	$3.08M	Buy	88,362 +9,000	+11%	+$313K	0.35%	69
2020 Q2	$2.46M	Sell	79,362 -28,496	-26%	-$884K	0.3%	80
2020 Q1	$3.34M	Sell	107,858 -13,578	-11%	-$420K	0.53%	49
2019 Q4	$4.51M	Sell	121,436 -2,073	-2%	-$77.1K	0.57%	38
2019 Q3	$4.21M	Buy	123,509 +22,766	+23%	+$776K	0.6%	38
2019 Q2	$4.14M	Buy	100,743 +11,920	+13%	+$490K	0.63%	32
2019 Q1	$3.58M	Buy	88,823 +1,552	+2%	+$62.5K	0.58%	33
2018 Q4	$3.61M	Buy	87,271 +21,908	+34%	+$907K	0.64%	29
2018 Q3	$2.73M	Hold	65,363	–	–	0.45%	63
2018 Q2	$2.25M	Buy	65,363 +24,750	+61%	+$852K	0.39%	90
2018 Q1	$1.37M	Sell	40,613 -135	-0.3%	-$4.54K	0.25%	102
2017 Q4	$1.4M	Buy	40,748 +3,041	+8%	+$105K	0.24%	102
2017 Q3	$1.28M	Sell	37,707 -6,476	-15%	-$219K	0.24%	100
2017 Q2	$1.41M	Buy	44,183 +2,067	+5%	+$65.9K	0.22%	114
2017 Q1	$1.37M	Sell	42,116 -2,056	-5%	-$66.7K	0.21%	111
2016 Q4	$1.36M	Sell	44,172 -2,900	-6%	-$89.4K	0.24%	106
2016 Q3	$1.51M	Buy	+47,072	New	+$1.51M	0.28%	98